Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13483)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 15, 2019 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kopel J, Pena-Hernandez C, Nugent K. Evolving spectrum of diabetic nephropathy. World J Diabetes 2019; 10(5): 269-279 [PMID: 31139314 DOI: 10.4239/wjd.v10.i5.269] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v10/i5/269.htm |
| Number | Citing Articles |
| 1 |
Simone Renner, Andreas Blutke, Sebastian Clauss, Cornelia A. Deeg, Elisabeth Kemter, Daphne Merkus, Rüdiger Wanke, Eckhard Wolf. Porcine models for studying complications and organ crosstalk in diabetes mellitus. Cell and Tissue Research 2020; 380(2): 341 doi: 10.1007/s00441-019-03158-9
|
| 2 |
Nur Samsu, Maria Irene Bellini. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/1497449
|
| 3 |
Alina Mihaela Stanigut, Camelia Pana, Manuela Enciu, Mariana Deacu, Bogdan Cimpineanu, Liliana Ana Tuta. Hypoxia-Inducible Factors and Diabetic Kidney Disease—How Deep Can We Go?. International Journal of Molecular Sciences 2022; 23(18): 10413 doi: 10.3390/ijms231810413
|
| 4 |
Yongzhang Qin, Suzhen Wu, Fengxia Zhang, Xueyan Zhou, Cong You, Fei Tan. N6‐methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE‐RAGE pathway. Environmental Toxicology 2023; 38(11): 2772 doi: 10.1002/tox.23917
|
| 5 |
D. A. Shipilova, O. A. Nagibovich, N. A. Shchukina. Doppler ultrasoundgraphy capability in the evaluation of renal circulation in patients with type 2 diabetes mellitus and chronic kidney disease. Bulletin of the Russian Military Medical Academy 2020; 22(3): 99 doi: 10.17816/brmma50542
|
| 6 |
Qun Wang, Yonglin Wang, Wen Liu, Dingyan Lu, Yang Jin, Nian Tang, Ya Shi, Zipeng Gong, Weiyi Tian, Ting Liu, Dong Hyun Kim. Mechanisms Underlying the Differences in the Pharmacokinetics of Six Active Constituents of Huangqi Liuyi Decoction between Normal and Diabetic Nephropathy Mouse Models. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/2481654
|
| 7 |
Xue Xue, Xin-Yan Jin, Xing-Lan Ye, Ke-Ying Li, Jia-Xuan Li, Xue-Han Liu, Juan Bai, Qiang Liu, Bing-Rui Zhang, Xin-Rong Zou, Jun Yuan, Chun-Li Lu, Fang-Fang Zhao, Jian-Ping Liu, Xiao-Qin Wang. Ophiocordyceps sinensis preparations combined with the renin–angiotensin system inhibitor for diabetic kidney disease treatment: an umbrella review of systematic reviews and network meta-analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1360633
|
| 8 |
Qi Jin, Tongtong Liu, Yuan Qiao, Donghai Liu, Liping Yang, Huimin Mao, Fang Ma, Yuyang Wang, Liang Peng, Yongli Zhan. Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1185317
|
| 9 |
Stein I. Hallan, Marius A. Øvrehus, Manjula Darshi, Daniel Montemayor, Knut A. Langlo, Per Bruheim, Kumar Sharma. Metabolic Differences in Diabetic Kidney Disease Patients with Normoalbuminuria versus Moderately Increased Albuminuria. Kidney360 2023; 4(10): 1407 doi: 10.34067/KID.0000000000000248
|
| 10 |
Hongyu Yu, Jian Ma, Yueru Gu, Wei Zou, Na Zhao. Serum cell division cycle 42 reflects the development and progression of diabetic nephropathy in patients with diabetes mellitus. Experimental and Therapeutic Medicine 2024; 27(5) doi: 10.3892/etm.2024.12473
|
| 11 |
Marijana Petrovic, Stanko Petrovic, Katarina Obrencevic. Vitamin D Deficiency - New Insights. 2023; doi: 10.5772/intechopen.106717
|
| 12 |
Xun Fang, Jun Hu, Hongyan Zhou. Knock-Down of Long Non-Coding RNA ANRIL Suppresses Mouse Mesangial
Cell Proliferation, Fibrosis, Inflammation via Regulating
Wnt/β-Catenin and MEK/ERK Pathways in Diabetic
Nephropathy. Experimental and Clinical Endocrinology & Diabetes 2022; 130(01): 30 doi: 10.1055/a-1185-9283
|
| 13 |
Jerome Ndudi Asiwe, Emuesiri Goodies Moke, Nicholas Asiwe, Godwin D. Yovwin, Bartholomew Chukwuebuka Nwogueze, Tarela Melish Elias Daubry. Dryopteris dilatata leaf extract ameliorates streptozotocin-induced diabetic nephropathy in male Wistar rat. Nutrire 2022; 48(1) doi: 10.1186/s41110-022-00186-4
|
| 14 |
·依明江 迪丽拜尔. Progress in the Treatment of Diabetes Nephropathy with Traditional Chinese Medicine. Advances in Clinical Medicine 2023; 13(08): 13505 doi: 10.12677/ACM.2023.1381885
|
| 15 |
Iuliia Azarova, Elena Klyosova, Alexey Polonikov. Single Nucleotide Polymorphisms of the RAC1 Gene as Novel Susceptibility Markers for Neuropathy and Microvascular Complications in Type 2 Diabetes. Biomedicines 2023; 11(3): 981 doi: 10.3390/biomedicines11030981
|
| 16 |
Dongning Liang, Hanwen Mai, Fangyi Ruan, Haiyan Fu. The Efficacy of Triptolide in Preventing Diabetic Kidney Diseases: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.728758
|
| 17 |
Li-Hsin Chang, Chii-Min Hwu, Yi-Chun Lin, Chin-Chou Huang, Justin G.S. Won, Harn-Shen Chen, Liang-Yu Lin. Soluble Tumor Necrosis Factor Receptor Type 1 Levels Exhibit A Stronger Association With Renal Outcomes Than Traditional Risk Factors in Chinese Subjects With Type 2 Diabetes Mellitus. Endocrine Practice 2020; 26(10): 1115 doi: 10.4158/EP-2020-0114
|
| 18 |
Shaomin Shi, Lihua Ni, Ling Gao, Xiaoyan Wu. Comparison of Nonalbuminuric and Albuminuric Diabetic Kidney Disease Among Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.871272
|
| 19 |
Elahe Soltani-Fard, Sina Taghvimi, Farzaneh Karimi, Farzaneh Vahedi, Seyyed Hossein Khatami, Hamid Behrooj, Mojdeh Deylami Hayati, Ahmad Movahedpour, Hassan Ghasemi. Urinary biomarkers in diabetic nephropathy. Clinica Chimica Acta 2024; 561: 119762 doi: 10.1016/j.cca.2024.119762
|
| 20 |
Luis D'Marco, Xavier Guerra-Torres, Iris Viejo, Luis Lopez-Romero, Alejandra Yugueros, Valmore Bermúdez. Non-albuminuric Diabetic Kidney Disease Phenotype: Beyond Albuminuria. European Endocrinology 2022; 18(2): 102 doi: 10.17925/EE.2022.18.2.102
|
| 21 |
Xin Zhang, Chen-gang Zhou, Li-jia Ma. Role of GDF-15 in diabetic nephropathy: mechanisms, diagnosis, and therapeutic potential. International Urology and Nephrology 2024; doi: 10.1007/s11255-024-04179-2
|
| 22 |
A. В. Bagriy, M. V. Khomenko, O. I. Shverova, E. R. Titievskaya. Therapy approaches in diabetic nephropathy (review of literature). Nephrology (Saint-Petersburg) 2021; 25(1): 18 doi: 10.36485/1561-6274-2021-25-1-18-30
|
| 23 |
Ning-Ning Hou, Cheng-Xia Kan, Na Huang, Yong-Ping Liu, En-Wen Mao, Yu-Ting Ma, Fang Han, Hong-Xi Sun, Xiao-Dong Sun. Relationship between serum Dickkopf-1 and albuminuria in patients with type 2 diabetes. World Journal of Diabetes 2021; 12(1): 47-55 doi: 10.4239/wjd.v12.i1.47
|
| 24 |
Pengyu Wang, Qing Lan, Qi Huang, Ruyi Zhang, Shuo Zhang, Leiming Yang, Yan Song, Tong Wang, Guandi Ma, Xiufen Liu, Xiying Guo, Youzhi Zhang, Chao Liu. Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation. Biology 2024; 13(8): 597 doi: 10.3390/biology13080597
|
| 25 |
Ángelo Torres-Arévalo, Yéssica Nahuelpán, Katherin Muñoz, Claudia Jara, Claudio Cappelli, Agnieszka Taracha-Wiśniewska, Claudia Quezada-Monrás, Rody San Martín. A2BAR Antagonism Decreases the Glomerular Expression and Secretion of Chemoattractants for Monocytes and the Pro-Fibrotic M2 Macrophages Polarization during Diabetic Nephropathy. International Journal of Molecular Sciences 2023; 24(13): 10829 doi: 10.3390/ijms241310829
|
| 26 |
Yongxia Lu, Wei Wang, Jingyu Liu, Min Xie, Qiang Liu, Sufang Li. Vascular complications of diabetes: A narrative review. Medicine 2023; 102(40): e35285 doi: 10.1097/MD.0000000000035285
|
| 27 |
Yu Han, Shufei Wei, Chao Liu, Ying Nie, Shizhao Yuan, Yinghua Ma, Yile Zhao, Guying Zhang. Effect and Mechanisms of Huangqi-Shanzhuyu in the Treatment of Diabetic Nephropathy based on Network Pharmacology and In Vitro Experiments. Combinatorial Chemistry & High Throughput Screening 2024; 27(14): 2078 doi: 10.2174/0113862073241153231003094411
|
| 28 |
Adel E. Berbari. Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection. International Journal of Cardiology Hypertension 2020; 7: 100058 doi: 10.1016/j.ijchy.2020.100058
|
| 29 |
Libo Liu, Yuquan Zhou, Xin Zhao, Xueyao Yang, Xueqi Wan, Ziyu An, Huan Zhang, Jinfan Tian, Changjiang Ge, Xiantao Song. Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Alleviate Diabetic Kidney Disease in Rats by Inhibiting Apoptosis and Inflammation. Frontiers in Bioscience-Landmark 2023; 28(9) doi: 10.31083/j.fbl2809203
|
| 30 |
Yuwen Liu, Ran Zhang, Jiaqi Zou, Hao Yin, Mengyao Zhao, Liming Zhao. The impact of chitooligosaccharides with a certain degree of polymerization on diabetic nephropathic mice and high glucose‐damaged HK‐2 cells. Food Science & Nutrition 2024; 12(6): 4173 doi: 10.1002/fsn3.4078
|
| 31 |
Timothy L. Middleton, Steven Chadban, Lynda Molyneaux, Mario D'Souza, Maria I. Constantino, Dennis K. Yue, Margaret McGill, Ted Wu, Stephen M. Twigg, Jencia Wong. Young adult onset type 2 diabetes versus type 1 diabetes: Progression to and survival on renal replacement therapy. Journal of Diabetes and its Complications 2021; 35(11): 108023 doi: 10.1016/j.jdiacomp.2021.108023
|
| 32 |
Hasandeep Singh, Rajanpreet Singh, Arshdeep Singh, Harshbir Singh, Gurpreet Singh, Sarabjit Kaur, Balbir Singh. Role of oxidative stress in diabetes-induced complications and their management with antioxidants. Archives of Physiology and Biochemistry 2023; : 1 doi: 10.1080/13813455.2023.2243651
|
| 33 |
Linlin He, Kai Shen, Lei He, Yuqing Chen, Zhiyuan Tang. The Mechanism of Plantaginis Semen in the Treatment of Diabetic
Nephropathy based on Network Pharmacology and Molecular Docking
Technology. Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24(3): 363 doi: 10.2174/1871530323666230915100355
|
| 34 |
Qun Wang, Ya Shi, Zengguang Wu, Xinli Song, Jinfang Luo, Hong Yang, Xiaolan Chen, Xingde Liu. Effects of Huangqi Liuyi Decoction in the Treatment of Diabetic Nephropathy and Tissue Distribution Difference of its Six Active Constituents Between Normal and Diabetic Nephropathy Mouse Models. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.934720
|
| 35 |
Zhuo Xu, Ke Cai, Shu-Lan Su, Yue Zhu, Feng Liu, Jin-Ao Duan. Salvianolic acid B and tanshinone IIA synergistically improve early diabetic nephropathy through regulating PI3K/Akt/NF-κB signaling pathway. Journal of Ethnopharmacology 2024; 319: 117356 doi: 10.1016/j.jep.2023.117356
|
| 36 |
Yasamin Rajabloo, Maryam Saberi-Karimian, Sara Saffar Soflaei, Gordon A. Ferns, Majid Ghayour-Mobarhan. Syndecans and diabetic complications: A narrative review. The American Journal of the Medical Sciences 2024; 368(2): 99 doi: 10.1016/j.amjms.2024.04.017
|
| 37 |
Zeng Zhang, Yanyan Wang, Fengzhu Zhou, Siyu Xu, Xinyi Zhang, Yueying Ma, Yifei Liu, Yanming He, Mohamed Afifi. Astragaloside IV Protects against Diabetic Nephropathy by Inhibiting FUNDC1‐Dependent Mitochondria‐Associated Endoplasmic Reticulum Membranes. Journal of Food Biochemistry 2024; 2024(1) doi: 10.1155/2024/2602406
|
| 38 |
Xuelian Zhang, Haiqing Zhu, Xiaoyan Xing, Chunyu Zhang. <p>Association Between Cannabinoid Receptor-1 Gene Polymorphism and the Risk of Diabetic Nephropathy Among Patients with Type 2 Diabetes Mellitus</p>. Pharmacogenomics and Personalized Medicine 2020; : 591 doi: 10.2147/PGPM.S278897
|
| 39 |
Dan Liang, Lu Liu, Yulin Qi, Feng Nan, Ju Huang, Shiyun Tang, Jianyuan Tang, Nianzhi Chen. Jin-Gui-Shen-Qi Wan alleviates fibrosis in mouse diabetic nephropathy via MHC class II. Journal of Ethnopharmacology 2024; 324: 117745 doi: 10.1016/j.jep.2024.117745
|
| 40 |
Daniela Patinha, Carla Abreu, Carla Carvalho, Olga Mariana Cunha, Mariana Mota, Joana Afonso, Teresa Sousa, António Albino-Teixeira, Carmen Diniz, Manuela Morato. Adenosine A2A and A3 Receptors as Targets for the Treatment of Hypertensive-Diabetic Nephropathy. Biomedicines 2020; 8(11): 529 doi: 10.3390/biomedicines8110529
|
| 41 |
Efstratios Moralidis, Emmanouil Papanastasiou, Triantafyllos Didangelos, Ilias Hilidis, Anastasios Siountas, Georgios Arsos. Determination of the glomerular filtration rate in patients with type 2 diabetes: An assessment of the agreement between 51Cr-EDTA plasma clearance and 99mTc-DTPA plasma clearance, 99mTc-DTPA renography and plasma creatinine prediction equation. Diabetes Research and Clinical Practice 2020; 161: 108079 doi: 10.1016/j.diabres.2020.108079
|
| 42 |
José María Mora-Gutiérrez, María A. Fernández-Seara, Rebeca Echeverria-Chasco, Nuria Garcia-Fernandez. Perspectives on the Role of Magnetic Resonance Imaging (MRI) for Noninvasive Evaluation of Diabetic Kidney Disease. Journal of Clinical Medicine 2021; 10(11): 2461 doi: 10.3390/jcm10112461
|
| 43 |
Samuel N. Heyman, Itamar Raz, Jamie P. Dwyer, Roni Weinberg Sibony, Julia B. Lewis, Zaid Abassi. Diabetic Proteinuria Revisited: Updated Physiologic Perspectives. Cells 2022; 11(18): 2917 doi: 10.3390/cells11182917
|
| 44 |
Wesley Hiser, Xinjin Zhou. Renal biopsy in patients with diabetes: Yesterday, today, and tomorrow. Diabetic Nephropathy 2021; 1(2): 59 doi: 10.2478/dine-2022-0001
|
| 45 |
E. B. Popykhova, A. N. Ivanov, T. V. Stepanova, D. D. Lagutina, A. A. Savkina. Diabetic Nephropathy – possibilities of early laboratory diagnostics and course prediction (review of literature). Russian Clinical Laboratory Diagnostics 2021; 66(10): 593 doi: 10.51620/0869-2084-2021-66-10-593-602
|
| 46 |
Ning Xu, Jie Liu, Xiangling Li. Therapeutic role of mesenchymal stem cells (MSCs) in diabetic kidney disease (DKD). Endocrine Journal 2022; 69(10): 1159 doi: 10.1507/endocrj.EJ22-0123
|
| 47 |
Jiao Luo, Jiahong Jiang, Hongjian Huang, Feifei Jiang, Zeru Xu, Zijun Zhou, Hong Zhu. C-peptide ameliorates high glucose-induced podocyte dysfunction through the regulation of the Notch and TGF-β signaling pathways. Peptides 2021; 142: 170557 doi: 10.1016/j.peptides.2021.170557
|
| 48 |
Qun Wang, Ya Shi, Xingde Liu, Ting Liu, Yongjun Li, Xinli Song, Xiaolan Chen, Yang Jin, Wen Liu, Yonglin Wang, Zipeng Gong, Adil Denizli. Pharmacokinetic Difference of Six Active Constituents of Huangqi Liuyi Decoction between Control and Diabetic Nephropathy Mouse Models. International Journal of Analytical Chemistry 2022; 2022: 1 doi: 10.1155/2022/7602992
|
| 49 |
Juan M. Buades, Lourdes Craver, Maria Dolores Del Pino, Mario Prieto-Velasco, Juan C. Ruiz, Mercedes Salgueira, Patricia de Sequera, Nicanor Vega. Management of Kidney Failure in Patients with Diabetes Mellitus: What Are the Best Options?. Journal of Clinical Medicine 2021; 10(13): 2943 doi: 10.3390/jcm10132943
|
| 50 |
Siska Darmayanti, Ronny Lesmana, Anna Meiliana, Rizky Abdulah. Genomics, Proteomics and Metabolomics Approaches for Predicting Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients. Current Diabetes Reviews 2021; 17(6) doi: 10.2174/1573399817666210101105253
|
| 51 |
Baihan Dong, Xiaona Liu, Siming Yu. Utilizing machine learning algorithms to identify biomarkers associated with diabetic nephropathy: A review. Medicine 2024; 103(8): e37235 doi: 10.1097/MD.0000000000037235
|
| 52 |
Shengfeng Wan, Shengkai Wan, Xiaojing Jiao, Huixia Cao, Yue Gu, Lei Yan, Yan Zheng, Peiyuan Niu, Fengmin Shao. Advances in understanding the innate immune‐associated diabetic kidney disease. The FASEB Journal 2021; 35(2) doi: 10.1096/fj.202002334R
|
| 53 |
Jinni Hong, Tingting Fu, Weizhen Liu, Yu Du, Junmin Bu, Guojian Wei, Miao Yu, Yanshan Lin, Cunyun Min, Datao Lin. Jiangtang Decoction Ameliorates Diabetic Kidney Disease Through the Modulation of the Gut Microbiota. Diabetes, Metabolic Syndrome and Obesity 2023; : 3707 doi: 10.2147/DMSO.S441457
|
| 54 |
Kounaina Khan, Subrahmanya Padyana. Diabetic nephropathy: Ayur‐nutri‐pharmaco approach. Food Safety and Health 2024; 2(3): 344 doi: 10.1002/fsh3.12048
|
| 55 |
Vijayakumar Natesan, Sung-Jin Kim. Diabetic Nephropathy - a Review of Risk Factors, Progression, Mechanism, and Dietary Management. Biomolecules & Therapeutics 2021; 29(4): 365 doi: 10.4062/biomolther.2020.204
|
| 56 |
Yu Ma, Yuanyuan Deng, Na Li, Ao Dong, Hongdian Li, Shu Chen, Sai Zhang, Mianzhi Zhang. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy. Journal of Ethnopharmacology 2023; 302: 115768 doi: 10.1016/j.jep.2022.115768
|
| 57 |
Marina Darenskaya, Elena Chugunova, Sergey Kolesnikov, Natalya Semenova, Isay Michalevich, Olga Nikitina, Anastasya Lesnaya, Lyubov Kolesnikova. Receiver Operator Characteristic (ROC) Analysis of Lipids, Proteins, DNA Oxidative Damage, and Antioxidant Defense in Plasma and Erythrocytes of Young Reproductive-Age Men with Early Stages of Type 1 Diabetes Mellitus (T1DM) Nephropathy in the Irkutsk Region, Russia. Metabolites 2022; 12(12): 1282 doi: 10.3390/metabo12121282
|
| 58 |
Medine Cumhur Cure, Erkan Cure. Comment on “Relationship Between Inflammatory Markers and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome After Coronary Angiography”. Angiology 2020; 71(8): 763 doi: 10.1177/0003319720902955
|
| 59 |
Huimin Chen, Yue Liu, Tingwei Zhang, Tongtong Huang, Yating Lang, Qinghao Sheng, Yingxiao Liu, Zhijuan Kong, Ying Gao, Shangwei Lu, Meilin Yang, Xia Li, Rong Wang, Zhimei Lv. Inhibition of the lncRNA 585189 prevents podocyte injury and mitochondria dysfunction by promoting hnRNP A1 and SIRT1 in diabetic nephropathy. Molecular and Cellular Endocrinology 2023; 578: 112065 doi: 10.1016/j.mce.2023.112065
|
| 60 |
Qing-Wei Gu, Qi Sun, Jie Wang, Wen-Sha Gu, Wei Wang, Xiao-Ming Mao. Effects of Glycemic Variability on Regulatory T Cells in Patients with Type 2 Diabetes and Kidney Disease. Diabetes, Metabolic Syndrome and Obesity 2023; : 2365 doi: 10.2147/DMSO.S413407
|
| 61 |
Atieh Mirzababaei, Faezeh Abaj, Zahra Roumi, Reza Amiri Khosroshahi, Yasaman Aali, Cain C. T. Clark, Mina Radmehr, Khadijeh Mirzaei. Consumption of red, white, and processed meat and odds of developing kidney damage and diabetic nephropathy (DN) in women: a case control study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59097-1
|
| 62 |
Liliany Souza de Brito Amaral, Cláudia Silva Souza, Hernando Nascimento Lima, Telma de Jesus Soares. Influence of exercise training on diabetic kidney disease: A brief physiological approach. Experimental Biology and Medicine 2020; 245(13): 1142 doi: 10.1177/1535370220928986
|
| 63 |
Jiang Liu, Xiao-Yun Song, Xiu-Ting Li, Mu Yang, Fang Wang, Ying Han, Ying Jiang, Yu-Xin Lei, Miao Jiang, Wen Zhang, Dong-Qi Tang. β-Arrestin-2 enhances endoplasmic reticulum stress-induced glomerular endothelial cell injury by activating transcription factor 6 in diabetic nephropathy. World Journal of Diabetes 2024; 15(12): 2322-2337 doi: 10.4239/wjd.v15.i12.2322
Abstract(38) |
Core Tip(33) |
Full Article(HTML)(191)
|
Full Article with Cover (PDF)-15875K(9)
|
Audio-121K(4)
|
Peer-Review Report-252K(7)
|
Answering Reviewers-826K(5)
|
Supplementary Material-804K(5)
|
Full Article (PDF)-15687K(9)
|
Full Article (XML)-128K(5)
|
Times Cited (0)
|
Total Visits (502)
|
Open
|
| 64 |
Tsung-Hui Wu, Li-Hsin Chang, Chia-Huei Chu, Chii-Min Hwu, Harn-Shen Chen, Liang-Yu Lin, Karin Jandeleit-Dahm. Soluble tumor necrosis factor receptor 2 is associated with progressive diabetic kidney disease in patients with type 2 diabetes mellitus. PLOS ONE 2022; 17(4): e0266854 doi: 10.1371/journal.pone.0266854
|
| 65 |
Adel E. Berbari. Angiotensin receptor neprolysin inhibitors: a novel approach to prevent cardiorenal disease in diabetes mellitus. Journal of Hypertension 2020; 38(4): 608 doi: 10.1097/HJH.0000000000002378
|
| 66 |
Sreenithya Ravindran, Shankar Munusamy. Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease. Journal of Cellular Physiology 2022; 237(2): 1182 doi: 10.1002/jcp.30621
|
| 67 |
Stephen H. Sinclair, Stanley S. Schwartz. Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00843
|
| 68 |
Denisha R. Spires, Oleg Palygin, Vladislav Levchenko, Elena Isaeva, Christine A. Klemens, Sherif Khedr, Oksana Nikolaienko, Alison Kriegel, Xi Cheng, Ji-Youn Yeo, Bina Joe, Alexander Staruschenko. Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats. Physiological Genomics 2021; 53(6): 223 doi: 10.1152/physiolgenomics.00009.2021
|
| 69 |
Adnan Jassim Mohammed Al-Fartosy, Nadhum Abdulnabi Awad, Sadoun Abbas Alsalimi. Clinical markers and some trace elements in patients with type-2 diabetic nephropathy : Impact of insulin resistance. The Journal of Medical Investigation 2021; 68(1.2): 76 doi: 10.2152/jmi.68.76
|